CKAP4 in Extracellular Vesicle‐Derived From Podocyte Serves as a Non‐Invasive Diagnostic Biomarker for Diabetic Nephropathy and Promotes Vascular Calcification
Reliable non-invasive biomarkers for early detection of diabetic nephropathy (DN), a leading cause of chronic kidney disease, remain limited. In this study, we isolate urinary extracellular vesicles (uEVs) using wheat germ agglutinin (WGA)-conjugated magnetic beads and identify cytoskeleton-associated protein 4 (CKAP4) as a potential diagnostic biomarker for DN. Proteomic profiling and flow cytometry show that CKAP4 levels are significantly higher in uEVs from DN patients than in those from diabetic, non-diabetic renal disease (NDRD) and healthy control groups. Receiver operating characteristic (ROC) analysis demonstrates excellent diagnostic performance, with area under the curve (AUC) values of 0.9998 (sensitivity = 98.77%, specificity = 100%) for DN versus controls, and 0.9859 (sensitivity = 95.72%, specificity = 99.24%) for DN versus diabetes mellitus. CKAP4 levels, elevated even at early-stage DN, positively correlate with glomerulosclerosis, increasing with the severity of interstitial fibrosis and tubular atrophy (IFTA). Mechanistically, CKAP4-containing EVs derived from high glucose-treated podocytes promote vascular calcification in vascular smooth muscle cells via YAP signalling. These findings identify CKAP4 in podocyte-derived uEVs as a robust non-invasive biomarker for early DN detection and provide new insights into the vascular pathology associated with the disease.
Authors
- Yangtian Wang
- Dafa Ding (ORCID: https://orcid.org/0000-0002-9815-9938)
- Shuang Qu (ORCID: https://orcid.org/0009-0008-9889-3383)
- Heng Zhang (ORCID: https://orcid.org/0000-0002-1554-2051)
- Laping Chu (ORCID: https://orcid.org/0000-0002-1892-4530)
- Zen Ke (ORCID: https://orcid.org/0000-0002-7382-6810)
- Chong Wu (ORCID: https://orcid.org/0000-0002-9593-293X)
- Jia Meng (ORCID: https://orcid.org/0000-0003-3455-205X)
- Min Zhang (ORCID: https://orcid.org/0000-0002-2001-7147)
- Yang Bai (ORCID: https://orcid.org/0000-0003-0415-8262)
- Fang Lu (ORCID: https://orcid.org/0000-0002-8927-2437)
- Yanggang Yuan (ORCID: https://orcid.org/0000-0003-2764-9486)
- Meng Liu (ORCID: https://orcid.org/0000-0002-2934-7978)
- Jie Li (ORCID: https://orcid.org/0000-0002-3461-8816)
- Qian Li (ORCID: https://orcid.org/0000-0002-6833-5080)
- Lizhi Lv (ORCID: https://orcid.org/0000-0003-4265-4312)
- Liang Hong-wei (ORCID: https://orcid.org/0000-0003-2204-6731)
- Gang He (ORCID: https://orcid.org/0000-0001-5801-0525)
- Wu JunXiang (ORCID: https://orcid.org/0000-0003-1052-0643)
- Kaibin Lou
Institutions
- Jiangnan University (CN)
- China Pharmaceutical University (CN)
- Nanjing Drum Tower Hospital (CN)
- Wuxi Fourth People's Hospital (CN)
- Kangmei Pharmaceutical (China) (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Extracellular Vesicles
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1002/jev2.70208
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health
- National Natural Science Foundation of China